TABITHA KOERNER: Open Payments
NPI 1356823033 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 37 payments from 10 companies in 2025. Trend: 2023 $496 · 2024 $596 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $210 |
| Alkermes, Inc. | 6 | $139 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Corium, LLC | 1 | $22 |
Products named: VRAYLAR, ARISTADA, Auvelity, COBENFY, REXULTI, CAPLYTA, SPRAVATO, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
